Cross-Platform Comparison of Computer-assisted Image Analysis Quantification of In Situ mRNA Hybridization in

Timothy R Holzer1, Jeffrey C Hanson, Erin M Wray

  • 1Diagnostic and Experimental Pathology, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN.

Insights

Automated scoring of mRNA in situ hybridization (ISH) using software like HALO shows potential for accurate quantification of peptidylprolyl isomerase B (PPIB) mRNA in non-small cell lung cancer tissues.

Area of Science:

  • Pathology
  • Computational Biology
  • Oncology

Background:

  • Standardized computer-assisted scoring for mRNA in situ hybridization (ISH) is lacking.
  • Automated platforms offer potential for quantitative analysis of mRNA expression in tissue sections.

Purpose of the Study:

  • To systematically compare automated image analysis software for scoring mRNA ISH.
  • To evaluate the accuracy and sensitivity of different platforms in quantifying peptidylprolyl isomerase B (PPIB) mRNA.

Main Methods:

  • Optimized ISH for PPIB mRNA on non-small cell lung carcinoma tissue microarrays.
  • Compared 4 commercial software platforms (ImageScope, HALO, CellMap, Developer XD) against manual pathologist scoring.
  • Assessed accuracy, cell identification, and ease of visual interpretation.

Main Results:

  • Correlation observed between H-scores from Developer XD, ImageScope, and manual scoring (R=0.7955).
  • HALO demonstrated potentially higher sensitivity and no systematic bias.
  • ImageScope overestimated high-range PPIB ISH signals.

Conclusions:

  • HALO software shows promise for accurate and sensitive quantitative scoring of mRNA ISH.
  • Automated tools can assist pathologists in quantitative analysis, improving efficiency and consistency.

Related Concept Videos